Japan approves Medwave's BP (blood pressure) monitor:
This article was originally published in Clinica
Medwave has gained market go-ahead in Japan for its Vasotrac APM205A blood pressure monitoring system. The handheld device is designed for measuring a patient's blood pressure noninvasively on a continual basis, with updates available approximately every 15 heartbeats, says the St Paul, Minnesota. It will be distributed by Nihon Kohden, which may also incorporate a Vasotrac module into its own products in the future under an agreement with Medwave.
You may also be interested in...
Oncology R&D isn’t waning, but investment in neurology and psychiatry drug development are paying off in new drug approvals. Rapid growth in CDER non-malignant hematology approvals reflects longer, broader trend toward orphan drugs.
We clean out your Martin Luther King Day inbox so you don't have to.
Political worries aside, industry is confidently executing on focused strategies as it welcomes a new decade, even if a lack of deal news at the J.P. Morgan Healthcare Conference didn't excite investors.